Yaz, Yasmin and Ocella Side Effects and Lawsuit |
| |
Lawyers Represent Women Harmed by Yaz, Yasmin and Ocella |
| |
The History of Yaz, Yasmin and Ocella |
 |
Yasmin first appeared on the market in 2001 for use as an oral contraceptive. In 2006, Bayer Healthcare purchased the company that manufactured Yasmin and began marketing a nearly identical formulation which Bayer named Yaz. Yaz has become the most popular oral contraceptive in the United States, and it is sold worldwide.
In October 2006, the FDA expanded the approved use of Yaz to include treatment for the symptoms of premenstrual dysphonic disorder (PMDD), which is a severe form of PMS. Later, in January 2007, Yaz was further approved to treat acne in women who also wanted a contraceptive medication. |
| |
Side Effects of Yaz, Yasmin and Ocella |
 |
An array of side effects have been associated with the use of Yaz and the generic Ocella. These include:
- Pulmonary Embolism (PE)
- Deep Vein Thrombosis (DVT)
- Heart Attack
- Stroke
- Pancreatitis
- Gallbladder Disease
- Kidney Disease
- Liver Disease
- Death
All oral contraceptives produce an increased risk to women of abnormal blood clots, but Yaz, Yasmin and Ocella present higher risks than do other birth control pills on the market. All contraceptive drugs contain ethinylestradiol, which is a synthetic form of estrogen first approved for use by the FDA in 1943. It is widely regarded as medically safe, and only occasionally produces minor side effects.
Yaz, Yasmin and Ocella are unique in that a single pill contains 3 milligrams of a synthetic progestin known as drospirenone, which is not used in other oral contraceptive medicines. Drospirenone is believed to be the cause of a higher risk of blood clots associated with the use of Yaz, Yasmin and Ocella.
Drospirenone acts as a diuretic resulting in lower water retention among women who take Yaz, Yasmin and Ocella. Reduced water in the bloodstream coupled with elevated levels of potassium may be the cause of increased risks of blood clots. |
| |
Blood Clots Caused by Yaz, Yasmin and Ocella |
| |
Clotting within blood vessels is not uncommon and not necessarily dangerous. Clotting is, in fact, essential to the healing process for punctured blood vessels. When a clot grows, however, it may travel to a coronary artery and cause a heart attack, or it may move to the brain and produce a stroke or move to the lungs and result in pulmonary embolism.
Even women who never had a history of abnormal clotting have developed serious—even fatal—medical conditions after taking Yaz, Yasmin and Ocella. |
| |
What You Should Do |
 |
Your Health |
| If you or a loved one has suffered an injury or side effects following use of Yaz, Yasmin or Ocella, promptly consult your physician for an evaluation. |
Your Legal Rights |
| If you have been injured by taking one of these drugs, you may be entitled to compensation. You should act immediately to contact an attorney experienced in matters involving dangerous pharmaceuticals. |
| |
Our Lawyers Can Help |
 |
O'Steen & Harrison, PLC presently is handling legal claims against the manufacturers of Yaz, Yasmin and Ocella. We invite you to contact us for a free,
confidential consultation about your legal rights.
We represent patients throughout the United States. We can help you, too, wherever you live.
For free answers to your questions about Yaz, Yasmin and Ocella, please call us toll-free at
1-800-883-8888 or complete this online contact
form. |
|
 |
O'Steen & Harrison, PLC |
300 W. Clarendon Ave., Suite 400
Phoenix, Arizona 85013-3424
800.883.8888
info@vanosteen.com
|
 |
Current Consumer Cases |
|
Contact Us |
|
Why You Should Choose Us |
We have represented thousands of people, including some of the largest and most important injury cases ever
brought in the United States.
In the single largest damages case in the history of the world, our attorneys were selected by the Arizona Attorney
General as the only Arizona law firm to represent the State against American tobacco companies. As a result,
Arizona taxpayers will receive more than three billion dollars to cover the costs of treating tobacco-related
illnesses, maintain educational programs to prevent young people from smoking, and fund other important State
programs. |
Yaz, Yasmin and Ocella News |
N.J. Court Weighing Mass Tort Status for Lawsuits Over Birth Control Pills • New Jersey Law Journal • November 9, 2009
Bayer Sued, Accused of Hiding Yaz Risk to Boost Sales • Bloomberg • October 6, 2009
Bayer's Yaz Consumer's Death Probed by Swiss Agency • Bloomberg • September 26, 2009
Birth Control Pill Yaz Named in Lawsuit Against Bayer • The Record • August 24, 2009
More Yaz News Stories
|
|